Journal Editorial Report: Bill McGurn and Jillian Melchior on why Beijing is targeting the pro-democracy publisher who refuses to flee the city. Image: May James/Zuma Wire …read more […]
Stock prices have marched relentlessly higher in recent months, even as the former vice president maintains a lead over President Trump in the polls. …read more […]
US chipmaker Intel Corp. last week revealed a new technology for making transistors which is said to improve the performance of its next round of processors by as much as 20%.Intel (INTC) disclosed the so-called SuperFin technology for its existing 10-nanometer (nm) chip process node, describing it as its largest single, intra-node enhancement in the company’s history, which promises to deliver performance improvement comparable to a full-node transition. The 10nm SuperFin technology combines Intel’s FinFET transistors with Super metal insulator metal capacitor, the company said.“It is 20%, the largest intra-node jump ever in our history,” Raja Koduri, Intel’s chief architect, …read more […]
The U.S. shale industry has been one of the hardest-hit sectors in oil, leaving many drillers struggling to keep their heads above water …read more […]
Second-quarter corporate earnings season is beginning to wind down, but a host of retailers’ earnings results is still set to be a key focus this week. A slew of US housing reports will also be released, including data on housing starts, building permits and existing home sales. …read more […]
(Bloomberg) — Malaysia has long been a place where vast fortunes have been amassed over time. The Kuoks, Tehs and Queks are custodians of palm oil, property and banking empires that stretch back decades.That was until Covid-19, when the country’s low-key rubber industry — or more precisely, glove making — became one of the hottest on the planet.Wong Teek Son, who co-founded Riverstone Holdings Ltd. in the 1980s after working as a research chemist, last month became the fifth billionaire in the country from manufacturing gloves. He’s now worth $1.2 billion as shares of his company rallied almost sixfold from …read more […]
‘I can tell you that the data are remarkably clear that, on average, the stock markets, on average, corporate profits, do better during Democratic administrations than they do during Republican administrations,’ says Summers. …read more […]
Introduction To keep myself sharp and my skills honed, I routinely go to my library of investment books and re-read classics that have had an impact on me. This week I did a complete re-read of Joel Greenblatt’s classic “The Little Book That Beats The Market.” For any of you that are not familiar with the book, […] …read more […]
International Business Machines Corp (NYSE:IBM) was a growth stock, but today the main interest is the dividend yield. Currently, IBM yields over 5%. Very few stocks that are not REITs, MLPs, or BDCs, have a yield this high. Further, IBM recently raised the regular cash dividend for the 25th consecutive year making it a new Dividend […] …read more […]
Some much-needed optimism has made its way to the Street. The expectation that a vaccine against COVID-19 will be “widely distributed” by the middle of 2021 prompted an estimate revision from Goldman Sachs. Giving its projections for 2021 U.S. GDP a lift, the figure moves up from 5.6% to 6.2%. “We now expect that at least one vaccine will be approved by the end of 2020 and will be widely distributed by the end of 2021 Q2,” Goldman Sachs’ chief economist Jan Hatzius wrote in a note to clients. As for unemployment rates, the firm also anticipates an improvement, …read more […]
Contrarian Podcast and Breakout Point, today, and Dan David of Wolfpack Research was one of the presenters. He explained why he sees Remark Holdings Inc (NASDAQ:MARK) as a good short. Remark’s Stake In Sharecare, Ownership Of KanKan He said one of the most popular bull cases for Remark Holdings issued by promoters like David Portnoy, is […] …read more […]
Biotech stocks came under pressure in the week ended Aug. 14 amid mixed earnings news flow from the sector. FDA decisions scheduled for the week also produced adverse outcomes. Eagle Pharmaceuticals Inc (NASDAQ: EGRX) and Fennec Pharmaceuticals Inc (NASDAQ: FENC) received complete response letters for their respective regulatory applications, while a decision on Eton Pharmaceuticals Inc’s (NASDAQ: ETON) eye inflammation drug hadn’t come by the Aug. 10 decision date.The week, however, saw a signing spree by coronavirus vaccine developers, which stitched up manufacturing as well as supply deals.Here are the key catalysts for the unfolding week.ConferencesVirtual Keystone Symposia: Advances in …read more […]
Retail pharmacy chains Walgreens and CVS Health have been struggling to fight intense competition from Amazon and Walmart. They have also been under pressure due to decline in reimbursement rates and lower prices of generic drugs.Aside from enhancing their digital capabilities, Walgreens and CVS have been aggressively focusing on healthcare services to improve their revenues.Using the TipRanks’ Stock Comparison tool, we will compare these two drug store chains to see which stock offers the most compelling investment opportunity.Walgreens Boots Alliance (WBA)Even before the COVID-19 pandemic, Walgreens was finding it difficult to thrive due to a competitive retail environment and changing …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
